Men whose prostate cancer comes back after surgery are more likely to survive if, along with the usual radiation, they also take drugs to block male hormones.
The finding, published Wednesday in The New England Journal of Medicine, comes from a long-running study that experts say will help clarify treatment for many patients.
Chronic graft-versus-host disease (cGVHD) is a prevalent and highly lethal condition affecting stem cell transplant recipients. Unfortunately, biopsies are a painful, invasive and slow procedure that cause discomfort to patients and does not yield rapid results. The National Cancer Institute seeks licensees to commercialize this improved method for detection of diseases that are characterized by the presence of rapidly-dividing cells using deuterated water as a label for dynamic measurement of in vivo cellular kinetics.
Date: February 22, 2017
Time: 7:30 a.m. – 8:00 a.m. Registration and Networking 8:00 a.m. – 9:30 a.m. Program
Curious about Lean Startup? What does it really mean and why is everyone talking about it? Lean is a way of thinking that can shorten cycles for developing products and business startups. It is a logical, scientific approach that helps businesses and entrepreneurs draw distinct lines between the fuzzy dream in their head and the reality on the ground. Best of all it teaches us how to create a deep, lasting relationship with the most important person our business will ever know: our customers.
Come join moderator Bob Smith, a serial entrepreneur and Lean Startup instructor and a panel of experienced Lean practitioners as they provide an overview of the process and how it can be used during any phase of the business life cycle; startup to new product development.
As part of REDI’s 20th Anniversary, we’ve created a new retention program aimed at solidifying relationships with the City’s leading businesses: Rockville Key Visits, or RKVs for short.
REDI is joined on the monthly visits by representatives of the Mayor & City Council, our Board of Directors, and partner economic development organizations.
RKVs are arranged with businesses that are major employers, operating in a priority industry, and/or exhibiting fast growth potential. The program creates an open line of communication to discuss the opportunities and challenges facing the local business community, which benefits all parties through a regular exchange of information and resources.
The first RKV took us to Supernus Pharmaceuticals, which focuses on developing and commercializing products for the treatment of central nervous system disorders and employs over 160 in its Rockville headquarters. As a major employer operating in the region’s important biotech cluster with strong potential for growth, Supernus was a great visit to kick off RKV!
President Donald Trump wants to remake the Food and Drug Administration. And he happens to have a “fantastic person” in mind to do it, he said Tuesday — someone who will turn the agency into an industry-friendly shop that cranks out new cures on the double.
With over 75 scientific ventures to its name, Flagship’s startup network has now generated 16 IPOs and $19 billion in aggregate value over 17 years.
Things were going well, but Flagship Pioneering (formerly Flagship Ventures) still felt the need for a name change in December of last year.
When: Thursday February 16, 2017 from 5:00 PM to 7:00 PM EST
Location: Growlers 227 E Diamond Ave Gaithersburg, MD 20877
Johns Hopkins Montgomery County Campus is also a site for the popular Osher Lifelong Learning Institute. Geared toward retirees, these non-credit classes cover topics including opera, literature, history, politics and more.
The campus is home to approximately 35 research companies and entrepreneurs. Scientists on campus are studying cervical cancer, Alzheimer’s disease, cell therapy, proteins and other health issues. Other companies focus on technology, medical devices and consulting services. The Rockville Science Center’s administrative offices are located here. Start-up companies, second-stage businesses and more established companies are welcome.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the issuance on January 24, 2017 of a seventh patent (number 9,549,940) by the United States Patent and Trademark Office (USPTO) covering Trokendi XR®, its novel once-daily extended-release topiramate product. The patent provides protection for the product with expiration that is no earlier than 2027.
In a unique collaboration, a concurrent degree program featuring Penn State Harrisburg’s master of business administration and the Penn State College of Medicine’s doctorate in biomedical sciences allows students to get on a fast track to jobs that combine scientific research with positions of management responsibility. The concurrent program gives students an edge in a highly competitive field by providing them with a foundation in management in addition to specialization in biomedical science.
The coming $1.1 billion acquisition of CoverMyMeds LLC – Ohio’s first tech startup ” unicorn” – is a huge win for the Ohio Third Frontier program.
McKesson Corp., one of the three biggest U.S. health-care products distributors, announced Wednesday it would acquire the fast-growing Columbus software maker in a deal that could grow to $1.37 billion depending on its financial performance over the next two years.
